Medmira Inc (MMIRF) 0.0219 $MMIRF MedMira Reports Second

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medmira Inc (MMIRF) 0.0219 $MMIRF

MedMira Reports Second Quarter Results for FY2016
Marketwired - Thu Mar 24, 4:30PM CDT
MedMira Inc. (MedMira) (TSX VENTURE: MIR) reported today on its financial results for the three and six month periods ended January 31, 2016.
MIR.VN: 0.035 (-0.005)

MedMira Announces Annual Shareholders Meeting Results
Marketwired - Mon Feb 01, 4:30PM CST
MedMira Inc. (MedMira) (TSX VENTURE: MIR) held its 2016 Annual General and Special Meeting of Shareholders on January 29, 2016. Incumbent Directors Mr. Hermes Chan, Mr. Marvyn Robar, and Mr. Romano Robusto were re-elected. Dr. Philippe Dro, the OnSite Lab Holdings AG representative, and Dr. Martial Lacroix were newly elected to the MedMira Board of Directors.
MIR.VN: 0.035 (-0.005)

MedMira Directors Granted Stock Options
Marketwired - Fri Jan 08, 4:01PM CST
MedMira Inc. (MedMira) (TSX VENTURE: MIR) has granted the Company's Board of Directors options to purchase common shares under its Stock Option Plan which was approved by shareholders at the Company's Annual General and Special Meeting on January 25, 2013. Mr. Marvyn Robar, Mr. Hermes Chan, Dr. Philippe Dro, and Mr. Romano Robusto were granted a total of 779,167 options at an exercise price of $0.10 per share and exercisable for a period of three years ending January 7, 2019.
MIR.VN: 0.035 (-0.005)

MedMira Reports Fiscal First Quarter 2016 Financial Results
Marketwired - Mon Dec 14, 4:32PM CST
MedMira Inc. (MedMira) (TSX VENTURE: MIR), reported today on its financial results for the three month period ending October 31, 2015. The Company recorded a 210% increase in revenue and a 202% increase in gross profit during the first quarter, compared to the same period last year.
MIR.VN: 0.035 (-0.005)

HIV/AIDS Testing - Global Strategic Business Report 2015-2020 - Screening Tests, Confirmatory Tests and Monitoring Tests
M2 - Wed Dec 09, 3:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/582pp5/hivaids_testing) has announced the addition of the "HIV/AIDS Testing - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands (volume) and US$ Thousand (value) by the following Product Segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 42 companies including many key and niche players such as - Abbott Laboratories, Inc. (US) - Abbott Molecular, Inc. (US) - Adaltis S.r.l. (Italy) - Alere (US) - Beckman Coulter, Inc. (US) - bioM?rieux SA (France) - Bio-Rad Laboratories, Inc. (US) - Calypte Biomedical Corporation (US) - Chembio Diagnostic Systems, Inc. (US) - Hologic, Inc. (US) - Fujirebio Europe N.V. (Belgium) - MedMira Inc. (Canada) - OraSure Technologies, Inc. (US) - Ortho-Clinical Diagnostics, Inc. (US) - Quest Diagnostics, Inc. (US) - Roche Diagnostics (Switzerland) - Siemens Healthcare Diagnostics, Inc. (US) - Trinity Biotech Plc. (Ireland) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. GROWTH DRIVERS AND MARKET TRENDS 3. HIV/AIDS STATISTICS 4. HIV/AIDS: UNDERSTANDING THE DISEASE 5. DIAGNOSIS OF HIV/AIDS 6. PRODUCT APPROVALS & LAUNCHES 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT GLOBAL PLAYERS 9. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 42 (including Divisions/Subsidiaries - 47) - The United States (33) - Canada (2) - Europe (8) - - France (2) - - Italy (2) - - Rest of Europe (4) - Asia-Pacific (Excluding Japan) (4) For more information visit http://www.researchandmarkets.com/research/58...ds_testing
ABT: 44.72 (-0.20), DGX: 84.70 (-0.55), TRIB: 12.10 (-0.41), HOLX: 38.10 (-0.41), OSUR: 7.00 (-0.03)

MedMira Debuts Reveal(R) G4 Rapid HIV Test at National HIV Prevention Conference
Marketwired - Mon Dec 07, 8:22AM CST
Editors Note: There is an image associated with this press release.
MIR.VN: 0.035 (-0.005)

MedMira Reports 2015 Fourth Quarter and Year End Financial Results
Marketwired - Tue Nov 24, 4:31PM CST
MedMira Inc. (MedMira) (TSX VENTURE: MIR) reported today on its financial results for the quarter and year ended July 31, 2015. The Company recorded a 60% increase in revenue and a 52% increase in gross profit at the fiscal year end compared to the prior year.
MIR.VN: 0.035 (-0.005)

MedMira Receives FDA Approval for the Reveal(R) G4 Rapid HIV-1 Antibody Test
Marketwired - Mon Oct 19, 9:01AM CDT
Editors Note: There is a photo associated with this press release.
MIR.VN: 0.035 (-0.005)

IIROC Trade Halt - Medmira Inc.
Newsfile Corp - Mon Oct 19, 7:20AM CDT
The following issues have been halted by IIROC:

MedMira Closes Investment from OnSite Lab
Marketwired - Tue Sep 08, 8:28AM CDT
MedMira Inc. (MedMira) (TSX VENTURE: MIR) has closed the CAD $5 million equity investment with OnSite Lab Holding AG (OnSite Lab) announced September 2, 2015. OnSite Lab is the Company's controlling shareholder and has previously made investments in MedMira totalling CAD $18.7 million.
MIR.VN: 0.035 (-0.005)

MedMira Targets Technology Promotion with Latest Investment from OnSite Lab
Marketwired - Wed Sep 02, 7:30PM CDT
MedMira Inc. (MedMira) (TSX VENTURE: MIR) is entering into a CAD $5 million investment with OnSite Lab Holding AG (OnSite Lab) to increase promotion and brand building to position the Company's proprietary Rapid Vertical Flow (RVF) Technology(TM) as a dominant platform in the rapid diagnostics industry.
MIR.VN: 0.035 (-0.005)

MedMira Board Reinforces Biotech Bench Strength with New Appointment
Marketwired - Mon Aug 17, 3:30PM CDT
MedMira Inc. (MedMira) (TSX VENTURE: MIR) announced today that controlling shareholder, OnSite Lab Holdings AG (OnSite Lab) has appointed Dr. Philippe Dro as its representative on the Company's Board of Directors, effective as of August 7, 2015. Dr. Dro replaces Dr. Michael Sidler who has served on MedMira's Board since 2012.
AGN: 253.01 (-0.18), MIR.VN: 0.035 (-0.005)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 360

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 519

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 55

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 349

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 113

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 328

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 79

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading

Top 5 Most Recently Viewed Articles

Venezuela's Political Shift and Its Impact on Global Oil Markets

Updated Category News Views 122

Venezuela's Dramatic Political Changes and Market Reactions Recent events in Venezuela have created quite a stir. With the U.S. capturing Nicolás Maduro, the country's president, and extraditing him for trial, one might expect a major upheaval in financial and commodity markets. Surprisingly, the markets seem largely unaffected by this significant geopolitical shift....

Continue Reading
Paradigm Health Pushes Innovative FDA Trial Initiative

Updated Category News Views 27

The FDA's Real-Time Game Changer Just up and submitting their convincing response to the FDA, Paradigm Health's grabbing headlines with a trailblazing initiative right out of Columbus, Ohio. The FDA's Real-Time Clinical Trials (RTCT) proof-of-concept has been a field where Paradigm wields its AI-driven wand, proposing a plan that promises to streamline clinical trial...

Continue Reading
DSV A/S Launches Major Share Buyback Program Announcement

Updated Category News Views 74

DSV A/S Launches Major Share Buyback Program Company Announcement No. 1130 In a strategic effort to boost shareholder value, DSV A/S has launched a share buyback program. This initiative officially began on July 24, 2024, and is expected to wrap up on October 22, 2024. The company plans to repurchase its own shares totaling up to DKK 1,500 million, which corresponds to a...

Continue Reading
Insights into the Growth of the Global Fondant Market Trends

Updated Category News Views 230

Exploring the Global Fondant Market Trends The fondant market is rapidly evolving, driven by a surge in consumer preferences for aesthetically pleasing dessert options. Recent research identifies that the fondant market size, valued at approximately USD 520.45 Million, is anticipated to reach around USD 898.79 Million by 2034, reflecting a robust compound annual growth...

Continue Reading
Innocan Pharma's Strategic Move: Private Placement Details

Updated Category News Views 110

Innocan Pharma's Exciting Private Placement Initiative Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) has announced a significant financial move by planning a non-brokered private placement. This initiative aims to issue up to 3,500,000 units, priced at C$0.20 each, bringing in gross proceeds of up to C$700,000. This offering is designed to expedite the...

Continue Reading